Raghava Sriramaneni

Company: CytomX Therapeutics

Job title: Scientist II, Cancer Immunology

Seminars:

Harnessing Multifunctional Nanoparticles to Enhance In Situ Vaccination Effect With Radiation & Immunotherapy in Preclinical Mouse Models 1:45 pm

Introducing the cutting-edge fusion of nanotechnology, radiation therapy, and immunotherapy to amplify the in situ vaccination effect for robust anti-tumor immune responses Navigating techniques to implant tumors on syngeneic and knockout mouse models to assess radiation therapy and ICI effects Uncovering the mechanism of action, PK/PD and efficacy of this method, and highlighting the potential…Read more

day: Conference Day One - Track 2 - Post Lunch

Topic: Mouse models (CDX, PDX and more) 4:35 pm

Reviewing the reasons and context for use Spotlighting methods to optimize translatability to patients Determining strategies for combination efficacy and safety between ICI with small molecules/ADCs/chemotherapiesRead more

day: Conference Day One - Track 1 - Afternoon